Consequently, polymorphisms within the IL-1 gene—particularly the variable number of tandem repeats (VNTR) polymorphism of IL-1Ra—may be significant for donor selection and could contribute to optimizing GVHD prophylaxis and therapeutic outcomes [ 30 ].
← all excerpts
Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms.
1
—
—